{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:48:08Z","timestamp":1770817688868,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,12,25]],"date-time":"2011-12-25T00:00:00Z","timestamp":1324771200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1007\/s10620-011-2013-3","type":"journal-article","created":{"date-parts":[[2011,12,24]],"date-time":"2011-12-24T07:49:18Z","timestamp":1324712958000},"page":"1349-1357","source":"Crossref","is-referenced-by-count":37,"title":["Use of Nucleoside (Tide) Analogues in Patients with Hepatitis B-Related Acute Liver Failure"],"prefix":"10.1007","volume":"57","author":[{"name":"The Acute Liver Failure Study Group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doan Y.","family":"Dao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuel","family":"Seremba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Veeral","family":"Ajmera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corron","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"Hynan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,25]]},"reference":[{"key":"2013_CR1","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1056\/NEJM199312163292508","volume":"329","author":"WM Lee","year":"1993","unstructured":"Lee WM. Acute liver failure. N Engl J Med. 1993;329:1862\u20131872.","journal-title":"N Engl J Med"},{"key":"2013_CR2","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/gut.14.12.927","volume":"14","author":"J Scotto","year":"1973","unstructured":"Scotto J, Opolon P, Eteve J, Vergoz D, Thomas M, Caroli J. Liver biopsy and prognosis in acute liver failure. Gut. 1973;14:927\u2013933.","journal-title":"Gut"},{"key":"2013_CR3","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1111\/j.1872-034X.2008.00420.x","volume":"38","author":"HC Lee","year":"2008","unstructured":"Lee HC. Acute liver failure related to hepatitis B virus. Hepatol Res. 2008;38:S9\u2013S13.","journal-title":"Hepatol Res"},{"key":"2013_CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1365-2893.2005.00581.x","volume":"12","author":"CT Wai","year":"2005","unstructured":"Wai CT, Fontana RJ, Polson J, et al. Clinical outcome and virological characteristics of hepatitis B-related acute liver failure in the United States. J Viral Hepat. 2005;12:192\u2013198.","journal-title":"J Viral Hepat"},{"key":"2013_CR5","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","volume":"50","author":"AS Lok","year":"2009","unstructured":"Lok AS, McMahon BJ. Chronic hepatitis B: update 2009. Hepatology. 2009;50:661\u2013662.","journal-title":"Hepatology"},{"key":"2013_CR6","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1056\/NEJMra0801644","volume":"359","author":"JL Dienstag","year":"2008","unstructured":"Dienstag JL. Hepatitis B virus infection. N Engl J Med. 2008;359:1486\u20131500.","journal-title":"N Engl J Med"},{"key":"2013_CR7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/hep.21486","volume":"45","author":"M Kumar","year":"2007","unstructured":"Kumar M, Satapathy S, Monga R, et al. A randomized controlled trial of lamivudine to treat acute hepatitis B. Hepatology. 2007;45:97\u2013101.","journal-title":"Hepatology"},{"key":"2013_CR8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.1840060417","volume":"6","author":"J Bernuau","year":"1986","unstructured":"Bernuau J, Goudeau A, Poynard T, et al. Multivariate analysis of prognostic factors in fulminant hepatitis B. Hepatology. 1986;6:648\u2013651.","journal-title":"Hepatology"},{"key":"2013_CR9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1136\/bmj.2.6037.669","volume":"2","author":"IL Woolf","year":"1976","unstructured":"Woolf IL, El Sheikh N, Cullens H, et al. Enhanced HBsAb production in pathogenesis of fulminant viral hepatitis type B. Br Med J. 1976;2:669\u2013671.","journal-title":"Br Med J"},{"key":"2013_CR10","unstructured":"Dao DY, Hynan LS, Yuan HJ, et al. Two distinct subtypes of hepatitis B virus-related acute liver failure are separable by quantitative serum IgM anti-HBc and HBV DNA levels. Hepatology. Epub. 10\/10\/2011."},{"key":"2013_CR11","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.gastro.2009.06.006","volume":"137","author":"WM Lee","year":"2009","unstructured":"Lee WM, Hynan LS, Rossaro L, et al. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology. 2009;137:856\u2013864.","journal-title":"Gastroenterology"},{"key":"2013_CR12","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJM200010123431513","volume":"343","author":"R Reshef","year":"2000","unstructured":"Reshef R, Sbeit W, Tur-Kaspa R. Lamivudine in the treatment of acute hepatitis B. N Engl J Med. 2000;343:1123\u20131124.","journal-title":"N Engl J Med"},{"key":"2013_CR13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1478-3231.2004.0983.x","volume":"24","author":"H Schmilovitz-Weiss","year":"2004","unstructured":"Schmilovitz-Weiss H, Ben-Ari Z, Sikuler E, et al. Lamivudine treatment for acute severe hepatitis B: a pilot study. Liver Int. 2004;24:547\u2013551.","journal-title":"Liver Int"},{"key":"2013_CR14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2893.2005.00695.x","volume":"13","author":"HL Tillmann","year":"2006","unstructured":"Tillmann HL, Hadem J, Leifeld L, et al. Safety and efficacy of lamivudine in patients with severe acute or fulminant hepatitis B, a multicenter experience. J Viral Hepat. 2006;13:256\u2013263.","journal-title":"J Viral Hepat"},{"key":"2013_CR15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.2169\/internalmedicine.47.1061","volume":"47","author":"Y Miyake","year":"2008","unstructured":"Miyake Y, Iwasaki Y, Takaki A, et al. Lamivudine treatment improves the prognosis of fulminant hepatitis B. Intern Med. 2008;47:1293\u20131299.","journal-title":"Intern Med"},{"key":"2013_CR16","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)64980-2","volume":"156","author":"FV Chisari","year":"2000","unstructured":"Chisari FV. Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lessons from hepatitis B. Am J Pathol. 2000;156:1117\u20131132.","journal-title":"Am J Pathol"},{"key":"2013_CR17","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1053\/jhep.2000.19324","volume":"32","author":"GJ Webster","year":"2000","unstructured":"Webster GJ, Reignat S, Maini MK, et al. Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology. 2000;32:1117\u20131124.","journal-title":"Hepatology"},{"key":"2013_CR18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1440-1746.2004.03534.x","volume":"20","author":"A Tsubota","year":"2005","unstructured":"Tsubota A, Arase Y, Suzuki Y, et al. Lamivudine monotherapy for spontaneous severe acute exacerbation of chronic hepatitis B. J Gastroenterol Hepatol. 2005;20:426\u2013432.","journal-title":"J Gastroenterol Hepatol"},{"key":"2013_CR19","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-150-2-200901200-00100","volume":"150","author":"MF Sorrell","year":"2009","unstructured":"Sorrell MF, Belongia EA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. Ann Intern Med. 2009;150:104\u2013110.","journal-title":"Ann Intern Med"},{"key":"2013_CR20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM199910213411702","volume":"341","author":"JL Dienstag","year":"1999","unstructured":"Dienstag JL, Schiff ER, Wright TL, et al. Lamivudine as initial treatment for chronic hepatitis B in the United States. N Engl J Med. 1999;341:1256\u20131263.","journal-title":"N Engl J Med"},{"key":"2013_CR21","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM199512213332501","volume":"333","author":"JL Dienstag","year":"1995","unstructured":"Dienstag JL, Perrillo RP, Schiff ER, Bartholomew M, Vicary C, Rubin M. A preliminary trial of lamivudine for chronic hepatitis B infection. N Engl J Med. 1995;333:1657\u20131661.","journal-title":"N Engl J Med"},{"key":"2013_CR22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.7326\/0003-4819-148-7-200804010-00008","volume":"148","author":"R Loomba","year":"2008","unstructured":"Loomba R, Rowley A, Wesley R, et al. Systematic review: the effect of preventive lamivudine on hepatitis B reactivation during chemotherapy. Ann Intern Med. 2008;148:519\u2013528.","journal-title":"Ann Intern Med"},{"key":"2013_CR23","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1053\/ajkd.2001.28607","volume":"38","author":"WC Lee","year":"2001","unstructured":"Lee WC, Wu MJ, Cheng CH, Chen CH, Shu KH, Lian JD. Lamivudine is effective for the treatment of reactivation of hepatitis B virus and fulminant hepatic failure in renal transplant recipients. Am J Kidney Dis. 2001;38:1074\u20131081.","journal-title":"Am J Kidney Dis"},{"key":"2013_CR24","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/lt.21614","volume":"14","author":"PW Angus","year":"2008","unstructured":"Angus PW, Patterson SJ. Liver transplantation for hepatitis B: what is the best hepatitis B immune globulin\/antiviral regimen? Liver Transpl. 2008;14:S15\u2013S22.","journal-title":"Liver Transpl"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-2013-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-011-2013-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-011-2013-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T19:44:57Z","timestamp":1559245497000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-011-2013-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,25]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["2013"],"URL":"https:\/\/doi.org\/10.1007\/s10620-011-2013-3","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,25]]}}}